Silo Pharma, Inc. (SILO) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
アナリスト予想 一株当たり利益（EPS） $-0.56 および 売上高 $0.00B 来期予想.
一株当たり利益（EPS）実績推移: 2024: 実績 $-1.19 vs 予想 $-0.56 (下回る -112.5%). 2025: 実績 $-0.50 vs 予想 $-0.70 (上回る +28.6%). アナリスト精度: 54%.
EPS予測 — SILO
54%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.19
vs Est –$0.56
▼ 52.9% off
2025
Actual –$0.50
vs Est –$0.70
▲ 40.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
売上高予測 — SILO
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▲ 0.1% off
2025
Actual $0.000B
vs Est $0.000B
▲ 0.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
